Agilent Technologies (A) Capital Expenditures Growth (3y) (2012 - 2026)
Agilent Technologies (A) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | -6.49% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | -3.55% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 10.06% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | 7.36% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | 139.42% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -5.23% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | -1.12% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 9.89% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 15.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 10.06% |
| Jan 31, 2026 | 6.96% |
| Oct 31, 2025 | 9.93% |
| Jul 31, 2025 | 7.90% |
| Apr 30, 2025 | 21.22% |
| Jan 31, 2025 | 8.95% |
| Oct 31, 2024 | 14.47% |
| Jul 31, 2024 | 19.43% |
| Apr 30, 2024 | 49.22% |
| Jan 31, 2024 | 29.96% |
| Oct 31, 2023 | 45.98% |
| Jul 31, 2023 | 47.97% |
| Apr 30, 2023 | 19.98% |
| Jan 31, 2023 | 30.75% |
| Oct 31, 2022 | 32.64% |
| Jul 31, 2022 | 20.38% |
| Apr 30, 2022 | 17.95% |
| Jan 31, 2022 | 24.36% |
| Oct 31, 2021 | 19.87% |
| Jul 31, 2021 | 17.84% |